Dashboard
Manage Tickers

FEMY


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Dow Jumps Over 300 Points; Zapp Electric V...
06/20/2024 18:35:07

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

gold-rises-1-accenture-shares-surge-after-q3-results
Gold Rises 1%; Accenture Shares Surge Afte...
06/20/2024 16:00:55

deep-dive-into-femasys-stock-analyst-perspectives-4-ratings
Deep Dive Into Femasys Stock: Analyst Pers...
06/20/2024 16:00:13

hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
06/20/2024 15:34:47

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

femasys-receives-ce-mark-approval-from-the-eu-mdr-for-its-femaseed-femvue-femcerv-and-femcath-products
Femasys Receives CE Mark Approval From The...
06/20/2024 12:34:47

hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
05/09/2024 17:40:40

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

femasys-q1-2024-gaap-eps-017-beats-019-estimate-sales-271140k-miss-776500k-estimate
Femasys Q1 2024 GAAP EPS $(0.17) Beats $(0...
05/09/2024 12:41:08

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10...

chardan-capital-maintains-buy-on-femasys-maintains-12-price-target
Chardan Capital Maintains Buy on Femasys, ...
04/01/2024 12:25:20

Chardan Capital analyst Keay Nakae maintains Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-maintains-buy-on-femasys-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on Femas...
04/01/2024 10:43:45

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10...

femasys-q4-eps-019-beats-021-estimate-sales-21311k-miss-24000k-estimate
Femasys Q4 EPS $(0.19) Beats $(0.21) Estim...
03/29/2024 03:38:55

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9....

chardan-capital-reiterates-buy-on-femasys-maintains-12-price-target
Chardan Capital Reiterates Buy on Femasys,...
03/21/2024 16:54:09

Chardan Capital analyst Keay Nakae reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-femasys-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
03/21/2024 10:29:26

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $10 price target.

femasys-announces-topline-data-from-pivotal-trial-for-femaseed-for-treatment-of-infertility-says-in-the-severe-male-factor-cohort-findings-show-24-of-women-became-pregnant-after-femaseed-femaseed-pregnancy-rate-by-cycle-was-more-than-double-historic-intrauterine-insemination-rate
Femasys Announces Topline Data From Pivota...
03/20/2024 12:18:26

femasys-completes-first-in-office-commercial-procedure-with-femaseed-infertility-solution
Femasys Completes First In-Office Commerci...
03/06/2024 14:02:20

femasys-highlights-its-femaseed-product-says-it-is-expected-to-serve-as-a-first-line-therapeutic-option-that-is-substantially-lower-cost-with-significantly-less-risk-than-assisted-reproductive-methods
Femasys Highlights Its FemaSeed Product, S...
02/28/2024 14:03:53

first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks
First Lady Jill Biden Unveils $100M In Fed...
02/21/2024 17:24:52

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
02/19/2024 21:30:44

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 17:31:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)